Guizhou Meijiao Co., Ltd Report issue

Government Phase 1

Organization Overview

First Clinical Trial
2010
NCT01264666
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Guizhou Meijiao Co., Ltd, China

Active Ingredients

Drugs in Phase 1 Trials (3)

chinese tea flavor liquor (1 trial)

guizhou meijiao (1 trial)

meijiao (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 3